Targetted polypeptide for specificity of liver cancer blood vessel
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- ZHONGSHAN HOSPITAL FUDAN UNIV
- Publication Date
- 2004-12-08
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1
Abstract
Description
technical field
[0001] The invention belongs to the field of biotechnology, relates to protein polypeptides, in particular to a polypeptide that can specifically bind to blood vessels of liver cancer tumors. Background technique
[0002] my country is a high-incidence area of liver cancer in the world. According to statistics, about 200,000 people die of liver cancer every year, accounting for about half of the global liver cancer deaths. Modern medicine has conducted scientific research on liver cancer for more than a hundred years. Although many achievements have been made, the overall 5-year survival rate of liver cancer patients is still only about 3%. The biggest obstacle to improving the prognosis of liver cancer is its extremely high invasion and metastasis. Even with radical surgical resection, 50% of patients will develop metastasis or recurrence within 5 years. Therefore, in-depth study of the internal mechanism of liver cancer metastasis and recurrence and the ...